Malaysia’s ISR Statistics
These statistics are compilations of sources from various IRBs & CRM internal data.
ISRs approved by Ethics Committees in 2015
201 new ISR trials were approved in 2015 by the various IRBs (%94 of CRM’s 2015 KPI 1).
Note:
The number reported includes ISRs approved for MOH and non-MOH sites, using the data reported monthly by the 13 ECs in Malaysia.
EC = Ethics Committee; ISR = Industry Sponsored Research.
No. of Trials approved by ECs in Malaysia in 2015 (n=201)
By therapeutic area, Oncology trials accounted for the highest number of trials with a total of 26 studies followed by Cardiology (21 trials) and Epidemiology (18 trials).
No. of Trials Approved by ECs in 2015 According to Phase
Note:
BE studies are not included as it is not a trial phase. The number reported includes ISRs approved for MOH and non-MOH sites, using the data reported monthly by the 13 ECs in Malaysia.
EC = Ethics Committee; ISR = Industry Sponsored Research
Number of ISR/IIR Hybrid Trials Approved for Each State in 2015 (n=457)
Kuala Lumpur had the highest number of ISR/IIR hybrid trials followed by Penang and Selangor.
Notes:
The number reported for each state includes ISR approved for MOH and non-MOH sites, using the data reported monthly by the 13 ECs in Malaysia The number represents individual ISR/IIR hybrid at each state; there may be duplicates of the same trial at other states with different PIs.
201 new trials were approved in 2015.
IIR = Investigator Initiated Research; ISR = Industry Sponsored Research
No. of Sites Involved in Clinical Trials in 2015 According to State
201 new ISR trials were approved in 2015 with a total of 370 individual sites. Selangor accounted for 86 sites, followed by Penang with 57 sites and Sabah with 45 sites.
Note: 370 sites involved in 201 trials.
Top 10 Most Active Sites in 2015
Hospital Umum Sarawak was the most active site in 2015 with 34 trials, followed by Hospital Kuala Lumpur (26 trials) and Hospital Pulau Pinang (22 trials).
